학술논문

Long-Term Follow-up of Bendamustine Plus Rituximab Regimen in 69 Treatment Naive (TN) Patients with Waldenstrom Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)
Document Type
Journal
Source
BLOOD; NOV 15 2022, 140 p3627-p3628, 2p. Supplement: 1
Subject
Language
English
ISSN
15280020